MedTrace Logo

Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy

NCT04663672 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2020-12-11

No results posted yet for this study

Summary

This study evaluates whether a scent applied during exposure therapy and during subsequent sleep will increase the durability of treatment effects for individuals with fear of spiders, contamination, and enclosed spaces.

Conditions

  • Claustrophobia
  • Obsessive-Compulsive Disorder
  • Arachnophobia

Interventions

OTHER

Experimental Scent

Participants will sleep in the presence of the exposure scent, delivered by an Airwick Essential Oils diffuser

OTHER

Control Scent

Participants will sleep in the presence of a novel scent, delivered by an Airwick Essential Oils diffuser

OTHER

No-Scent Control

Participants will sleep in the presence of an odorless control vehicle, delivered by an Airwick Essential Oils diffuser

BEHAVIORAL

In-Vivo Exposure

Participants will receive 40 minutes of in-vivo exposure therapy to feared targets in the presence of a distinctive exposure scent.

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-29
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04663672 on ClinicalTrials.gov